Zobrazeno 1 - 10
of 16
pro vyhledávání: '"J. S. Nixon"'
Publikováno v:
International Journal of Computer Sciences and Engineering. 7:1805-1819
Autor:
J. S. Nixon, S. E. Wilkinson
Publikováno v:
Cellular and Molecular Life Sciences CMLS. 54:1122-1144
The T lymphocyte has a vital part to play in maintaining the host response to bacterial and viral infection and also appears to play a key pathological role in autoimmune diseases such as rheumatoid arthritis. In this review, we summarize the signall
Autor:
P.J. Malsher, Michael J. Broadhurst, K. M. K. Bottomley, Geoffrey Lawton, Brown Paul Anthony, M.I. Cooper, J. S. Nixon, Ian Reginald Kilford, Neera Borkakoti, William Henry Johnson, N. Ballantyne, A.J. Eatherton, B.M. Sutton, E. J. Lewis
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 7:2299-2302
A novel series of MMP inhibitors has been identified. The compounds are potent selective inhibitors of collagenase with good solubility and oral bioavailability. One compound, designated Ro32-3555, has been selected for development as a cartilage pro
Autor:
J. Bishop, M. Brewster, J. M. Budd, David Bradshaw, F. Rose, Brown Paul Anthony, William Henry Johnson, K. M. K. Bottomley, Michael J. Broadhurst, K. Wilson, J. S. Nixon, B.M. Sutton, A. Greenham, L H Elliott, E. J. Lewis
Publikováno v:
British Journal of Pharmacology. 121:540-546
1. Ro 32-3555 (3(R)-(cyclopentylmethyl)-2(R)-[(3,4,4-trimethyl-2,5-dioxo-1- imidazolidinyl)methyl]-4-oxo-4-piperidinobutyrohydroxamic acid) is a potent, competitive inhibitor of human collagenases 1, 2 and 3 (Ki values of 3.0, 4.4 and 3.4 nM, respect
Autor:
Hans Werner Lahm, Pat Eyers, Brown Paul Anthony, Michael J. Broadhurst, L H Elliott, John M. Budd, Trevor J. Hallam, Urs Röthlisberger, David Bradshaw, Geoffrey Lawton, Amanda Whittle, J. S. Nixon, Maisie James, Hill Christopher Huw, Janet E. Merritt, Neera Borkakoti, William Henry Johnson, Balraj Krishnan Handa, K. M. K. Bottomley
Publikováno v:
Biochemical Journal. 323:483-488
N-terminal analysis of aggrecan fragments lost from bovine nasal cartilage cultured in the presence of recombinant human interleukin 1alpha revealed a predominant ARGSVIL sequence with an additional ADLEX sequence. Production of the ARGSVIL-containin
Autor:
H. Kumar, J. Bishop, Hill Christopher Huw, D. Westmacott, Geoffrey Lawton, Peter D. Davis, J. S. Nixon, David Bradshaw, Sandra E. Wilkinson, L H Elliott, E. J. Lewis, MJ Mulqueen, J. Wadsworth
Publikováno v:
Biochemical Society Transactions. 20:419-425
Autor:
Anthony D. Sedgwick, Peter D. Davis, L H Elliott, Geoffrey Lawton, J. S. Nixon, Sandra E. Wilkinson, Hill Christopher Huw
Publikováno v:
Biochemical and Biophysical Research Communications. 171:148-154
The inhibition of phosphorylase kinase by a number of protein kinase inhibitors was examined. Both K252a and staurosporine are potent inhibitors of phosphorylase kinase with IC50 values of 1.7 nM and 0.5 nM respectively. K252a shows a 300-fold select
Autor:
E J, Lewis, J, Bishop, K M, Bottomley, D, Bradshaw, M, Brewster, M J, Broadhurst, P A, Brown, J M, Budd, L, Elliott, A K, Greenham, W H, Johnson, J S, Nixon, F, Rose, B, Sutton, K, Wilson
Publikováno v:
British journal of pharmacology. 121(3)
1. Ro 32-3555 (3(R)-(cyclopentylmethyl)-2(R)-[(3,4,4-trimethyl-2,5-dioxo-1- imidazolidinyl)methyl]-4-oxo-4-piperidinobutyrohydroxamic acid) is a potent, competitive inhibitor of human collagenases 1, 2 and 3 (Ki values of 3.0, 4.4 and 3.4 nM, respect
Publikováno v:
Cellular signalling. 9(1)
Previous studies implicating a role for protein kinase C (PKC) in mediating stimulation of cellular responses by physiological agonists have relied on use of non-specific inhibitors or direct stimulation of PKC by phorbol esters. However, much of thi
Autor:
J S, Nixon, J, Bishop, D, Bradshaw, P D, Davis, C H, Hill, L H, Elliott, H, Kumar, G, Lawton, E J, Lewis, M, Mulqueen
Publikováno v:
Drugs under experimental and clinical research. 17(8)
Clarification of the precise role of protein kinase C (PKC) in cellular functional responses has been hampered by a lack of potent, selective inhibitors. The structural lead provided by staurosporine, a potent but non-selective protein kinase (PK) in